More on KNSA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+34.8% Growth)
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (7/28/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Kiniksa Pharmaceuticals Ltd. (NQ:KNSA)
Delayed: 62.84 -0.21 (0.33%)
Prev. Close $63.05  
Open$63.35 
52 Wk High$ 
52 Wk Low$ 
Day High$63.39 
Day Low$62.31 
P/E N/A  
EPS$ 
Volume619,962 


Jul 23, 2026 04:01 PM Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026
Jul 23, 2026 06:54 AM Kiniksa (KNSA) PT Raised to $75 at Goldman Sachs
Jul 13, 2026 06:28 AM Kiniksa (KNSA) PT Raised to $74 at Wells Fargo
Jul 13, 2026 06:28 AM Kiniksa (KNSA) PT Raised to $74 at Wells Fargo
Jul 6, 2026 04:43 PM Form 4 Kiniksa Pharmaceuticals For: Jul 01 Filed by: Malkani Dhiraj H
Jul 6, 2026 04:37 PM Form 3 Kiniksa Pharmaceuticals For: Jun 29 Filed by: Malkani Dhiraj H
Jun 29, 2026 06:38 AM Kiniksa (KNSA) PT Raised to $72 at Wedbush
Jun 2, 2026 04:52 PM Form 4 Kiniksa Pharmaceuticals For: May 29 Filed by: Quart Barry D
Jun 2, 2026 04:51 PM Form 4 Kiniksa Pharmaceuticals For: May 29 Filed by: Popovits Kimberly J
Jun 2, 2026 04:50 PM Form 4 Kiniksa Pharmaceuticals For: Jun 01 Filed by: Patel Sanj K
View All Articles

Entities mentioned with KNSA

View All Entities